Total Payments
$1,392
2024 Payments
$347.48
Companies
20
Transactions
71
Medicare Patients
10,844
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$1,392 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,392 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $531.61 | 29 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $126.16 | 8 | $0 (2024) |
| Smith+Nephew, Inc. | $122.09 | 1 | $0 (2023) |
| Novo Nordisk Inc | $105.13 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $56.57 | 4 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52.35 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $51.71 | 3 | $0 (2022) |
| Amarin Pharma Inc. | $38.68 | 2 | $0 (2021) |
| Dexcom, Inc. | $37.14 | 2 | $0 (2022) |
| Lundbeck LLC | $36.87 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $347.48 | 19 | ABBVIE INC. ($165.21) |
| 2023 | $310.53 | 12 | Smith+Nephew, Inc. ($122.09) |
| 2022 | $262.36 | 14 | ABBVIE INC. ($99.44) |
| 2021 | $471.67 | 26 | AbbVie Inc. ($214.95) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.39 | General |
| Category: GI | ||||||
| 09/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: UROLOGY | ||||||
| 09/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: PSYCHIATRY | ||||||
| 07/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: GI | ||||||
| 01/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: GI | ||||||
| 10/19/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,241 | 34,560 | $914,767 | $556,740 |
| 2022 | 25 | 2,898 | 26,723 | $783,965 | $484,085 |
| 2021 | 27 | 2,850 | 19,155 | $714,334 | $443,219 |
| 2020 | 21 | 1,855 | 8,823 | $452,532 | $269,907 |
Total Patients
10,844
Total Services
89,261
Medicare Billing
$1.8M
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 528 | 1,997 | $218,225 | $125,205 | 57.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 94 | 19,035 | $152,280 | $93,853 | 61.6% |
| 17108 | Destruction of birthmark, more than 50.0 sq cm | Office | 2023 | 111 | 138 | $98,670 | $64,527 | 65.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 249 | 279 | $87,885 | $51,757 | 58.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 249 | 306 | $73,440 | $45,349 | 61.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 138 | 10,381 | $51,905 | $30,924 | 59.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 174 | 196 | $48,020 | $28,200 | 58.7% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 167 | 289 | $28,900 | $18,525 | 64.1% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 70 | 72 | $18,000 | $17,640 | 98.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 94 | 128 | $21,760 | $14,244 | 65.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $14,700 | $11,692 | 79.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 78 | 79 | $18,565 | $10,331 | 55.7% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 139 | 153 | $16,065 | $9,641 | 60.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 166 | 288 | $15,840 | $9,562 | 60.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 54 | 113 | $10,735 | $5,566 | 51.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 68 | 73 | $9,855 | $5,565 | 56.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 69 | 69 | $8,970 | $4,212 | 47.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 205 | 227 | $5,675 | $2,292 | 40.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 38 | 39 | $5,655 | $2,113 | 37.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 68 | 70 | $4,200 | $1,989 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 286 | 426 | $1,774 | $1,692 | 95.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 20 | 21 | $1,890 | $1,051 | 55.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 37 | 41 | $738.00 | $553.91 | 75.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 24 | $840.00 | $233.20 | 27.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 18 | $180.00 | $22.25 | 12.4% |
About Bernadette Guia, N.P
Bernadette Guia, N.P is a Family healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1376911131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bernadette Guia, N.P has received a total of $1,392 in payments from pharmaceutical and medical device companies, with $347.48 received in 2024. These payments were reported across 71 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,392).
As a Medicare-enrolled provider, Guia has provided services to 10,844 Medicare beneficiaries, totaling 89,261 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Panorama City, CA
- Active Since 09/10/2015
- Last Updated 09/10/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1376911131
Products in Payments
- LINZESS (Drug) $382.89
- Linzess (Drug) $126.16
- COLLAGENASE SANTYL (Drug) $122.09
- CREON (Drug) $111.27
- Rybelsus (Drug) $71.81
- JARDIANCE (Drug) $70.91
- TRINTELLIX (Drug) $56.57
- XIFAXAN (Drug) $51.71
- GEMTESA (Drug) $42.41
- Vascepa (Drug) $38.68
- VIBERZI (Drug) $37.45
- Dexcom G6 Transmitter (Medical Supply) $37.14
- REXULTI (Drug) $36.87
- AREXVY (Drug) $31.00
- Kerendia (Drug) $27.16
- ZENPEP (Drug) $25.72
- MYRBETRIQ (Drug) $21.95
- NEXLETOL (Drug) $19.19
- Wegovy (Drug) $19.06
- TRULICITY (Drug) $18.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Panorama City
Tatyana Lebenkova
Family — Payments: $5,049
Family $5,049
Genice Schumann, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $2,760
Family $2,760
Diana Vargas
Family — Payments: $1,307
Family $1,307
Hilda Jacobo, Fnp-Bc, FNP-BC
Family — Payments: $898.63
Family $898.63
Alwyn Samson
Family — Payments: $897.74
Family $897.74
Roberto Minero, Fnp-C, FNP-C
Family — Payments: $420.98
Family $420.98